is contraction of the uterus at parturition. Moreover, premature activation of the OT system is thought to contribute to preterm labor, a major clinical problem in obstetrical practice. However, the molecular mechanisms linking activation of the OT receptor (OTR) to myometrial contractions are not fully understood. Here, we describe an in vitro system that should serve as a useful tool to study this question at a cellular level. The system consists of a collagen lattice contraction assay and two different human myometrial cell lines: a cell clone from a telomerase-immortalized human myometrial cell population (hTERT-C3) as well as a cell line derived from a primary culture of human myometrial cells (M11). Using this approach, we observed that 1 nM OT promoted an almost maximal effect on cell contraction in both cell lines tested. Furthermore, this dose-dependent, OT-induced contraction was antagonized by the specific OTR antagonist d(CH2)5[Tyr(Me) 2 ,Thr 4 ,Tyr-NH2 9 ]OVT as well as the clinically used antagonist atosiban. This cell line-based contraction assay enables the application of molecular tools aimed at suppressing or overexpressing specific genes. It is also amenable to high-throughput testing approaches. Therefore, this system represents a powerful and improved experimental model that should facilitate the study of the molecular signal transduction pathways involved in the uterotonic actions of OT. oxytocin receptor; myometrium; parturition; myometrial cell lines; mitogen-activated protein kinase; extracellular signal-regulated kinase 1/2 THE NONAPEPTIDE HORMONE OXYTOCIN (OT) has a wide spectrum of biological activities that are mediated through the OT receptor (OTR), a member of the heptahelical G proteincoupled receptor family (19) . The OTR is primarily associated with the G protein G␣ q/11 , and OTR activation results in a phospholipase C-mediated increase in intracellular calcium and inositol trisphosphate production (14) . In addition, coupling of the OTR to G␣ i and Gh has also been observed (15, 2) . The OTR is also linked to the MAP kinase pathway and is able to induce activation of ERK1/2 involving G␣ q , G␤/␥, and transactivation of the epidermal growth factor receptor (18) . One of the most recognized actions of OT is its capacity to induce uterine contraction at parturition. Indeed, at term, there is a marked increase in uterine OTR expression in all mammalian species studied, including the human (9, 11) . OT is also used clinically to induce or augment labor and to prevent or treat uterine bleeding postpartum. Because mice that are deficient in OT deliver normally, the importance of the OT/OTR system for inducing parturition has been questioned (12, 17) . However, the fact that the OT antagonist atosiban is able to delay preterm labor contractions in primates, including humans, argues in favor of an important role of the OT/OTR system in mediating uterine contractions preterm and possibly at term. In fact, atosiban is presently approved for clinical use in Europe to delay preterm labor.
Traditionally, the only bioassay to assess the effects of OT and of potential OT antagonists on uterine contractions consisted of freshly isolated uterine strips. For advanced studies on intracellular signaling mechanisms involved in mediating the contractile response in response to OTR activation, it is necessary to have the possibility to transfect cells with specific vectors that either overexpress or suppress specific genes in the target cells. This is difficult to achieve in freshly isolated tissues. Moreover, we wished to develop an assay system that allowed for the simultaneous analysis of a large number of samples and was possibly amenable to automated analysis. This prompted us to develop alternative in vitro systems using nontransformed, OT-responsive myometrial cell lines in combination with an in vitro cell contraction assay system. The present approach can be used to study the uterotonic activity of OT and any blockers thereof in a well-defined in vitro system of human myometrial cells.
MATERIALS AND METHODS
Tissue culture. Myometrial M11 cells were obtained from John A. Copland (Mayo Clinic College of Medicine, Jacksonville, FL). These cells were derived from dispersed primary human myometrial cells by repeated passage without the use of any immortalizing or transforming agent. M11 cells were maintained in DMEM high glucose (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (Hyclone, Logan, UT), penicillin, and streptomycin. Myometrial human telomerase reverse transcriptase (hTERT)-HM cells were obtained from W. E. Rainey (5). hTERT-HM cells represent a cell population of human myometrial cells that was immortalized by transfection with an expression vector containing the hTERT. hTERT-C3 cells represent a subclone that we selected by serial dilution. This procedure maintains telomere length and endows the cells with an unlimited life span in culture (5) . hTERT-C3 cells were maintained in DMEM-F-12 medium supplemented with 10% FBS and antibiotics. Both cell lines were cultured at 37°C in 5% CO 2. Cells were trypsinized at 90% confluency and plated in T175 flask at a 1:5 dilution every 4 -5 days.
Immunoblotting. The expression of cell markers was assessed by immunoblotting. Briefly, myometrial cells were plated onto 60-mm culture dishes and cultivated close to confluency on top of a collagen matrix. For monitoring MAP kinase activity, cells were serum starved for 2 days (M11 cells) or kept in DMEM-F-12 supplemented with only 0.5% FBS for 24 h (hTERT-C3 cells). Following OT treatment, cells were washed twice with ice-cold PBS and flash frozen in liquid nitrogen. Cells were lysed on ice with 250 l of lysate buffer containing 25 mM HEPES-NaOH (pH 7.4), 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 10% glycerol, 1% Triton X-100, and a mix of protease inhibitors (1 g/ml each aprotinin, pepstatin A, and leupeptin and 0.5 mM PMSF) and phosphatase inhibitors (50 mM NaF, 30 mM sodium pyrophosphate, and 1 mM sodium orthovanadate). Lysates were clarified by centrifugation at 15,000 g for 10 min at 4°C in a table top microcentrifuge. Total protein concentration was determined by a colorimetric assay using BSA as standard (BCA protein assay reagent kit; Pierce, Rockford, IL). Protein samples were denatured by boiling in Laemmli buffer [50 mM Tris ⅐ HCl (pH 6.8), 2% SDS, 10% glycerol, and 0.1 M ␤-mercaptoethanol] for 5 min and subjected to SDS-PAGE and Western blotting. Immunodetection involved antismooth muscle ␣-actin (A-0307), anti-caldesmon (C-4562) (both from Sigma-Aldrich, St. Louis, MO), anti-phospho-ERK1/2 (9106s), and anti-pan-ERK1/2 (9102) (Cell Signaling Technology, Beverly, MA) antibodies in conjunction with an appropriate second horseradish peroxidase C-conjugated antibody and a chemiluminescence detection system (SuperSignal; Pierce).
Collagen gel retraction assay. The present in vitro system used to measure myometrial cell contraction in response to OT was developed on the basis of a technique originally described by Dallot et al. (6) . Collagen type 1 from rat tail (Sigma) was resuspended overnight in 0.01 N HCl to prepare a 5 mg/ml stock solution and kept at 4°C until use. A working collagen solution was prepared by adding 5ϫ PBS and 0.1 N NaOH to maintain the pH between 7.0 and 7.5 and diluted to 1.5 mg/ml with "starvation medium" (DMEM-F-12 supplemented with 0.5% FBS). The previous step was performed on ice to avoid premature collagen polymerization. Immediately thereafter, 0.5 ml of the ice-cold neutralized collagen solution was added to individual wells of a 24-well plate and left at 37°C for 1 h to allow gelling of the collagen. One millliter of starvation medium containing 25,000 myometrial cells was layered onto each collagen lattice, and cells were left to settle for 2 h at 37°C. To allow contraction, each collagen lattice was detached from the bottom of the well with a small spatula and left overnight at 37°C in absence or presence of different concentrations of OT (Sigma). Contraction was stopped by fixing the lattices in PBS-4% paraformaldehyde, and the lattice was kept at 4°C until analysis. To assess the surface area of the lattices, the liquid of each well was aspirated and the plate photographed using the Alpha Innotech Imaging System (Alpha Innotech, San Leandro, CA) equipped with an Olympus C-5060 digital camera. The surface area was determined quantitatively using the analysis software package supplied with the imaging system. For each OT concentration, collagen contraction was determined in triplicate or quadruplicate and expressed as percentage contraction. Percentage contraction was taken as the percentage of lattice size diminution relative to the size area of the well.
[ 3 H]OT binding assay on cell membranes. The determination of OTR binding sites on cell membranes was assessed as described previously (10) . Cells including the collagen lattices on which they were grown were harvested in ice-cold lysate buffer [15 mM Tris ⅐ HCl (pH 7.4), 2 mM MgCl2, and 0.3 mM EDTA] supplemented with protease inhibitors as above and lysed using a polytron (Tissue Tearor; Biospec Products). Membranes were pelleted and resuspended in ice-cold membrane buffer [50 mM Tris ⅐ HCl (pH 7.4), 3 mM MgCl2, and protease inhibitors] and centrifuged again. Washed pellets were resuspended in a small volume of membrane buffer, and membrane protein content was assessed by BCA. For the binding procedure, 20 g of membranes were incubated with increasing concentrations of [ 3 H]OT (PerkinElmer Life Sciences, Boston, MA) for 60 min at 30°C. Specific binding was determined as the difference between total and nonspecific binding in the absence and presence of 10 M unlabeled OT, respectively. The dissociation constants (Kd) and the maximal receptor densities (Bmax) were obtained from the binding data using the software KELL (Biosoft). Data were represented graphically using GraphPad Prism version 4 (GraphPad Software, San Diego, CA).
Statistical data analysis.
Experimental results were expressed as means Ϯ SE. Student's t-test was used to determine statistical significance. A value of P Ͻ 0.05 was considered to be significant. For analysis of the dose-response curve of OT-induced contractions, including nonlinear sigmoidal, four-parameter logistic curve fitting, graphic representation, and ED 50 calculation, the program Prism, by GraphPad Software, was used.
RESULTS
Characterization of human myometrial cell lines M11 and hTERT-C3. Two different human myometrial cell lines were used in the present study: a cultured primary myometrial cell line (M11) and a clonal cell line originating from a telomeraseimmortalized myometrial cell population (hTERT-C3). To assess the cellular morphology, cells from both lines were cultured on a collagen matrix and photographed under phasecontrast optics. Both cell lines shared similar morphological characteristics that were typical of myometrial cells (Fig. 1A) . Cells of both lines featured an elongated shape and a central nucleus. Compared with M11 cells, hTERT-C3 cells were smaller in size and often exhibited a bulky shape. To further determine the status of cell differentiation in both cell lines, the expression levels of typical smooth muscle differentiation markers were assessed by Western blotting. As shown in ,Tyr-NH 2 9 ]OVT (OTA) (data not shown) (7). To assess the functionality of the demonstrated OTRs expressed on the myometrial cell lines, coupling to the MAP kinase pathway was determined using a phospho-ERK-specific antibody. Analysis by Western blotting demonstrated that OT application led to a dose-dependent increase in ERK1/2 phosphorylation (Fig. 3) . The response was highly sensitive, and a marked increase could be detected at a dose as low as 0.1 nM for both cell lines. Taken together, these results indicate that both myometrial cell lines share many features of primary uterine smooth muscle cells, including the expression of specific and functional OTRs.
OT-induced contraction of M11 and hTERT-C3 cells. As shown above, M11 and hTERT-C3 cells possess biochemical and morphological characteristics typical of myometrial cells. We were next interested to determine to what extent these cells also exhibited the prototypical physiological response of myometrial cells to OT stimulation, i.e., cellular contraction. To address this question, we developed an in vitro assay system consisting of a modified collagen lattice contraction assay that was based on a published procedure (6) . In contrast to the published procedure, in which cells were imbedded in a collagen matrix, in the present system cells are layered on top of a preformed collagen matrix. This has the advantage of a better solute accessibility of the cells forming a monolayer on top of the matrix. Cellular contraction leads to a decrease in the diameter of the collagen matrix. Furthermore, if cells are layered on top of the matrix, cellular contraction also induces a concave shape of the matrix with raised borders. Both types of matrix deformation contribute additively to a decrease in matrix surface if viewed perpendicularly from above (Fig. 4A) .
Using the present assay system, we observed a marked contraction exerted by hTERT-C3 cells in the absence of added OT (Fig. 4, A and B) . This basal contraction was dependent on the presence of attached living myometrial cells and was absent from collagen lattices without cells (data not shown). Addition of a saturating concentration of OT led to a further contraction of hTERT-C3 cells (Fig. 4, A and B) . This OT-induced contraction was fully antagonized by the OTR-specific antagonist OTA, supporting the idea that the OT-induced contraction in our assay occurred via an OTR-specific mechanism. Similar results were observed when M11 human myometrial cells were used (Fig. 4C) . The addition of the OT antagonist OTA led to a relaxation of hTERT-C3 cells below the level of basal contraction (Fig. 4B) . A similar trend was observed in M11 cells.
The basal as well as the OT-induced contractions were a hallmark of myometrial smooth muscle cells. This was clearly demonstrated when myometrial cells were replaced with human embryonic kidney-derived (HEK) 293 cells (Fig. 5) . Using these noncontractile cells, neither basal nor OT-induced contractions were detectable.
An extended dose-response experiment of the uterotonic activity of OT on hTERT-C3 cells showed that 1 nM OT, an agonist concentration corresponding to the previously determined K d of the OTR, induced an almost maximal contraction (Fig. 6) . The logarithmic EC 50 deduced from this experiment was Ϫ10.47 Ϯ 0.258 (mean Ϯ SE, n ϭ 4). This result is in full agreement with values determined with preterm and term uterine strips, using a classical uterine strip bioassay (1) .
To further confirm that OT-induced contractions were mediated by the OTR, we tested the effect of the OTR selective agonist [Thr 4 ,Gly 7 ]OT (TGOT; Ref. 8) . As shown in Fig. 7A , increasing amounts of TGOT led to a dose-dependent contrac- tion. We next tested the effect of atosiban, an OT and vasopressin V 1a antagonist in clinical use in Europe for the prevention of preterm labor. As demonstrated in Fig. 7B , the presence of a 100-fold excess of the antagonist totally blocked the contraction induced by 1 nM OT.
DISCUSSION
Here, we report for the first time the use of an in vitro collagen lattice retraction assay for the study the uterotonic activity of OT. As an integral component of the assay system, we have characterized two novel nontransformed human myometrial cell lines with respect to their biochemical and physiological OT response characteristics. In the present in vitro contraction assay, cells were layered on top of a preestablished collagen lattice, whereas in the original approach cells were embedded within the lattice (6) . With the present approach, less cells are needed per lattice (i.e., 25,000 vs. 150,000 cells). This is due to the fact that cells are concentrated in the same plane on the lattice surface rather than diluted in the entire volume of the collagen. The presumed higher level of cell-cell contacts also likely facilitates a concerted contraction of the entire layer. Moreover, we determined that leaving the cells on top of the collagen lattice for only 2 h was sufficient for the cells to settle down and be competent for OT-induced contraction. This is in contrast to the originally described procedure, where contraction was initiated only after 3 days in culture.
The use of clonal, immortalized, yet untransformed cells has notable advantages over a system using a heterogeneous cell population stemming from acutely isolated primary cells. Myometrial tissue is composed of different cell types, each differing with respect to the level of OTR expression (11), thus yielding an inhomogeneous population of primary cells. Using isolated cells from such a complex tissue may lead to a lack of consistency and reproducibility. The use of immortalized, yet nontransformed, myometrium cells like the ones used in this report thus has a distinct advantage over primary culture cells. An added benefit of the use of clonal cells is their almost infinite growth capacity, thus greatly facilitating the development of multiple consistent and reproducible assay systems. The present system should thus represent a valuable tool in the development of an integrative model of myometrial cells biology. The observations presented in this report were obtained using two different human myometrial cell lines: an established primary cultured cell line (M11) and a telomerase-immortalized myometrial cell clone (hTERT-C3). Our study shows that OVT (OTA) was added prior to OT addition. ERK1/2 activity was immunodetected in total cell lysates by Western blot using a specific phospho-ERK1/2 antibody. As a loading control, total MAP kinase immunoreactivity was assessed first by removing the phospho-ERK1/2 antibody by stripping the membrane and reprobing the latter with a total ERK1/2 antibody. The migration positions of ERK1 and ERK2 are indicated on the left. both cell lines exhibit phenotypes that are very similar to the primary cells from which they were derived in terms of morphology, OTR density, coupling of the activated OTR to the MAP kinase pathway, and the OT-induced contraction response curves. Overall, our data support the hTERT-C3 cell clone as a good model to study myometrial cells biology during the onset of labor, because this cell clone possesses several important characteristics of myometrial cells found at this stage of parturition. First, hTERT-C3 cells express similarly high levels of OTRs as the ones found in the myometrium at the onset of labor (3). Moreover, these receptors are also coupled to relevant signal transduction cascades, such as the activation of the MAP kinase ERK1/2 pathway. Finally, our data using the collagen retraction assay show a concentration-dependent response to OT as well as to the OTR-specific OT agonist TGOT that is indistinguishable from the one found with myometrial strips obtained from women at term (8, 13) .
When compared with M11 cells, hTERT-C3 cells exhibited a stronger OT-induced contractile response (Fig. 4) . hTERT-C3 cells also showed a higher OTR receptor density (B max ) and an apparently higher level of smooth-muscle ␣-actin (Fig. 1) . However, it remains to be determined whether any cause/effect relationships exist between these observations. Interestingly, in both cell lines tested, the presence of the OTR antagonist OTA inhibited not only OT-induced contractions but also reduced the basal, agonist-independent contraction. The effect of the antagonist on the basal uterine contraction can be explained either by its antagonistic activity per se on the uterotonic action of OT secreted in the medium by the cells themselves or by a possible reverse agonist activity on the OTR, as previously reported by Chini et al. (4) .
In conclusion, in this report we describe a new experimental model to study the uterotonic action of OT in vitro directly on cells, using a collagen retraction assay in conjunction with two different human myometrial cell lines. This new approach should help to define, at the cellular level, the molecular events occurring in the myometrium at normal labor and should help to discover efficient approaches to counter the molecular cascades leading to preterm labor. (16) 
